...
首页> 外文期刊>Circulation journal >Prediction of Thromboembolism in Patients With Hypertrophic Cardiomyopathy
【24h】

Prediction of Thromboembolism in Patients With Hypertrophic Cardiomyopathy

机译:肥厚性心肌病患者血栓栓塞预测

获取原文
           

摘要

Hypertrophic cardiomyopathy (HCM) is associatedwith a high incidence of cerebrovascular disease,transient cerebral ischemic attacks, and peripheralembolism, and therefore, high rates of morbidity andmortality.1 In a community-based Japanese patient cohort,the 5-year embolic event rate was 5.5% and thromboembolicevents were not rare in patients with HCM.2 Atrial fibrillation(AF) is one of the most common arrhythmias inHCM. A recent meta-analysis reported that the prevalenceof AF in HCM was 22.5% and the incidence of thromboembolismin HCM patients with AF was 27.1%.3 Furthermore,the incidence of thromboembolism in HCM patientswith AF is 3.8%, and age and left atrial enlargement areconsidered as risk factors for its incidence.
机译:肥厚性心肌病(HCM)与脑血管疾病,瞬时脑缺血性发作和外围栓塞的发病率很高,因此,在一个以社区为基础的日本患者队列中的发病率高,5年栓塞事件率为5.5 HCM.2心房颤动患者(AF)是最常见的心律失常的患者,%和血栓苄醇素二均未罕见。最近的荟萃分析报道,HCM中的患病率为22.5%,AF的血栓栓塞HCM患者的发病率为27.1%.3此外,HCM患者血栓栓塞的发病率为3.8%,而且由于AF为3.8%,而年龄和左侧大心房扩大作为其发病率的危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号